Published Erratum
doi: 10.3389/fphar.2024.1365927.
eCollection 2024.
Erratum: Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies
- PMID: 38288439
- PMCID: PMC10822909
- DOI: 10.3389/fphar.2024.1365927
Item in Clipboard
Published Erratum
Erratum: Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies
Front Pharmacol.
.
Abstract
[This corrects the article DOI: 10.3389/fphar.2023.1182644.].
Keywords: carbapenems; cefoperazone/sulbactam; coagulation disorders; hypofibrinogenaemia; tigecycline; β-lactam antibiotics.
Copyright © 2024 Frontiers Production Office.
Erratum for
-
Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies.Front Pharmacol. 2023 Jun 7;14:1182644. doi: 10.3389/fphar.2023.1182644. eCollection 2023. Front Pharmacol. 2023. PMID: 37351509 Free PMC article.
Similar articles
-
Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies.Front Pharmacol. 2023 Jun 7;14:1182644. doi: 10.3389/fphar.2023.1182644. eCollection 2023. Front Pharmacol. 2023. PMID: 37351509 Free PMC article.
-
Clinical characteristics and risk factors of tigecycline-associated hypofibrinogenaemia in critically ill patients.Eur J Clin Pharmacol. 2020 Jul;76(7):913-922. doi: 10.1007/s00228-020-02860-w. Epub 2020 Apr 30. Eur J Clin Pharmacol. 2020. PMID: 32355990 Free PMC article.
-
Comparison of Tigecycline or Cefoperazone/Sulbactam therapy for bloodstream infection due to Carbapenem-resistant Acinetobacter baumannii.Antimicrob Resist Infect Control. 2019 Mar 6;8:52. doi: 10.1186/s13756-019-0502-x. eCollection 2019. Antimicrob Resist Infect Control. 2019. PMID: 30886705 Free PMC article.
-
beta-Lactamase inhibition and in vitro activity of sulbactam and sulbactam/cefoperazone.Clin Infect Dis. 1997 Mar;24(3):494-7. doi: 10.1093/clinids/24.3.494. Clin Infect Dis. 1997. PMID: 9114205 Review.
-
Hypofibrinogenemia induced by high-dose tigecycline-case report and review of literature.Medicine (Baltimore). 2020 Oct 23;99(43):e22638. doi: 10.1097/MD.0000000000022638. Medicine (Baltimore). 2020. PMID: 33120753 Free PMC article. Review.
Publication types
LinkOut - more resources
Full Text Sources
